Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.
- Market Cap ₹ 8,503 Cr.
- Current Price ₹ 685
- High / Low ₹ 850 / 280
- Stock P/E 255
- Book Value ₹ 10.1
- Dividend Yield 0.16 %
- ROCE 52.4 %
- ROE 41.1 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 67.7 times its book value
- Debtor days have increased from 30.9 to 39.4 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | |
|---|---|---|
| 147 | 205 | |
| 128 | 159 | |
| Operating Profit | 18 | 46 |
| OPM % | 12% | 22% |
| 1 | 3 | |
| Interest | 1 | 1 |
| Depreciation | 3 | 3 |
| Profit before tax | 15 | 44 |
| Tax % | 26% | 24% |
| 11 | 34 | |
| EPS in Rs | 1.23 | 2.72 |
| Dividend Payout % | 0% | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 40% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 214% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 195% |
| 1 Year: | 49% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 41% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | |
|---|---|---|
| Equity Capital | 10 | 14 |
| Reserves | 26 | 112 |
| 7 | 1 | |
| 18 | 24 | |
| Total Liabilities | 62 | 151 |
| 29 | 60 | |
| CWIP | 5 | 1 |
| Investments | 0 | 5 |
| 28 | 86 | |
| Total Assets | 62 | 151 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | |
|---|---|---|
| 16 | 15 | |
| -18 | -33 | |
| -5 | 48 | |
| Net Cash Flow | -7 | 29 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | |
|---|---|---|
| Debtor Days | 23 | 39 |
| Inventory Days | 149 | 85 |
| Days Payable | 109 | 126 |
| Cash Conversion Cycle | 62 | -1 |
| Working Capital Days | -12 | 28 |
| ROCE % | 52% |
Documents
Announcements
-
Jeena Sikho Lifecare Limited Has informed About Publication Of Case Studies And Case Reports.
3h - Multiple Ayurvedic case studies published by Jeena Sikho Lifecare staff, notified to exchanges on 7 Jan 2026.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 2d
-
Jeena Sikho Lifecare Limited Has informed About Publication Of Case Studies And Case Reports.
3 Jan - Jeena Sikho Lifecare published seven Ayurvedic case studies/reports by MD and staff; web links provided (03 Jan 2026).
-
Jeena Sikho Lifecare Limited Has informed About Receipt Of NABH Certificate Of Accreditation For Sanganer Hospital.
1 Jan - NABH accreditation awarded to Sanganer Hospital (Panchakarma), Cert AH-2025-0412, valid till Nov 10, 2028.
-
Announcement under Regulation 30 (LODR)-Meeting Updates
1 Jan - Granted 218,875 ESOPs to 1,176 employees; exercise price Rs2; dated 01-01-2026.
Annual reports
Concalls
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
Aug 2025TranscriptAI SummaryPPT
-
Jul 2025TranscriptAI SummaryPPTREC
-
May 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptAI SummaryPPT REC
-
May 2024Transcript PPT
-
Feb 2024TranscriptAI SummaryPPT
-
Aug 2023TranscriptAI SummaryPPT
-
Aug 2023TranscriptAI SummaryPPT
Business Segment
a) Hospitals & Clinics Portfolio[1]
Jeena Sikho Lifecare Limited (JSLL) operates a network of 36 hospitals and 74 clinics/daycare centres across 21 states and 100+ cities in India. The hospitals have 1,530 operational beds, with another 518 beds in the pipeline.